Categories: BrainEHRNews

Ibogaine By David Dardashti Leverages Albert Einstein’s Corelation Between Photon Particles and Quantum Electrodynamics

Ibogaine By David Dardashti Revolutionizes Solar Energy Efficiency Through Radiation Generators

Einstein

A young and Handsome Albert Einstein

MIAMI, March 15, 2024 (GLOBE NEWSWIRE) — Ibogaine By David Dardashti, a cutting-edge clinic driven by developing unprecedented methodologies, is integrating Albert Einstein’s photoelectric effect to revolutionize the use of solar energy.

Solar Efficiency:

Through the use of natural and renewable energy, individuals will now able to optimize their use of solar energy. In order to create improved solar energy efficiency, Albert Einstein’s photoelectric effect must be accurately utilized. His theory on the wave frequencies of photons and electrons can be used to explain and replicate the energy flow in a more efficient way. Ibogaine By David Dardashti is adapting Einstein’s model of innovative energy efficiency to revolutionize solar energy. Through this breakthrough, radiation generators will be able to access more natural energy through detecting and counting the wavelengths of light flow. This new method of data distribution will account for the trends in quantum electrodynamics that account for the flow of light based on electricity which will lead to higher efficacy in the field of solar energy. The clinic is also striving to implement further methods and techniques to increase the awareness of solar energy efficiency. By using ibogaine to measure electric flow within the brain, Ibogaine By David Dardashti will be able to obtain more in-depth research and understanding of this phenomenon. As Albert Einstein once said, “The world is a dangerous place not because of the dangerous people but because of the people who don’t do anything to stop it.” This innovative clinic is continuously striving to do their part to revolutionize energy efficiency and be part of something bigger.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/cd74cc7a-32da-4a24-8f48-95287b8911c3

CONTACT: Gavriel Dardashti
+17869301880
gavriel@ibogaineclinic.com

Staff

Recent Posts

NervGen Pharma Announces Proposed Amendment to Warrants

Vancouver, British Columbia--(Newsfile Corp. - December 12, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB:…

5 hours ago

MyndTec Inc. Completes Ninth Tranche of Non-Brokered Private Placement

Mississauga, Ontario--(Newsfile Corp. - December 12, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"),…

7 hours ago

Dominari Holdings Announces Change of Record Date and Payment Date for $10 Million Cash Dividend

NEW YORK, Dec. 12, 2025 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) is pleased to announce…

7 hours ago

ISHI Health Launches Virtual Heart Failure Clinics in California and Arizona

SAN DIEGO, Dec. 12, 2025 /PRNewswire/ -- ISHI Health, an innovator in AI-enabled virtual cardiac…

7 hours ago

Zealthy Review 2026: How Zealthy Compares to FitRx and RoenRx for Weight Loss & GLP-1 Care

LOS ANGELES, CA / ACCESS Newswire / December 12, 2025 / The landscape of weight…

7 hours ago

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

ESTERO, FL / ACCESS Newswire / December 12, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP)…

7 hours ago